Studies
Neurology
Abdolahi M, Tafakhori A, Togha M et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics. 2017 Jun;69(6):371-378.
English
Abdolahi M, Tafakhori A, Togha M et al. The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients. Immunogenetics. 2017 Jun;69(6):371-378.
https://www.ncbi.nlm.nih.gov/pubmed/28478481
Neurology
No
07/20/2017
4109
McNamara RK, Asch RH, Lindquist DM et al. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids. 2017 May 9.
English
McNamara RK, Asch RH, Lindquist DM et al. Role of polyunsaturated fatty acids in human brain structure and function across the lifespan: An update on neuroimaging findings. Prostaglandins Leukot Essent Fatty Acids. 2017 May 9.
http://www.plefa.com/article/S0952-3278(16)30219-8/fulltext
Neurology
No
06/01/2017
4118
Dong Y, Xu M, Kalueff AV et al. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interl
English
Dong Y, Xu M, Kalueff AV et al. Dietary eicosapentaenoic acid normalizes hippocampal omega-3 and 6 polyunsaturated fatty acid profile, attenuates glial activation and regulates BDNF function in a rodent model of neuroinflammation induced by central interleukin-1β administration. Eur J Nutr. 2017 May 18.
https://link.springer.com/article/10.1007%2Fs00394-017-1462-7
Neurology
No
05/25/2017
4121
Andreone BJ, Wai Chow B, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017 May 3;94(3):581-594
English
Andreone BJ, Wai Chow B, Tata A, Lacoste B, Ben-Zvi A, Bullock K, Deik AA, Ginty DD, Clish CB, Gu C. Blood-Brain Barrier Permeability Is Regulated by Lipid Transport-Dependent Suppression of Caveolae-Mediated Transcytosis. Neuron. 2017 May 3;94(3):581-594.e5. doi: 10.1016/j.neuron.2017.03.043. Epub 2017 Apr 13.
https://www.ncbi.nlm.nih.gov/pubmed/28416077
Neurology
No
05/03/2017
3978
Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017 Jan 24;18(1):19.
English
Siegert E, Paul F, Rothe M, Weylandt KH. The effect of omega-3 fatty acids on central nervous system remyelination in fat-1 mice. BMC Neurosci. 2017 Jan 24;18(1):19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259863/
Neurology
Full text
01/24/2017
3910
Liu ZH, Yip PK, Priestley JV, Michael-Titus AT. A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma. 2017 Jan 13.
English
Liu ZH, Yip PK, Priestley JV, Michael-Titus AT. A Single Dose of Docosahexaenoic Acid Increases the Functional Recovery Promoted by Rehabilitation after Cervical Spinal Cord Injury in the Rat. J Neurotrauma. 2017 Jan 13.
https://www.ncbi.nlm.nih.gov/pubmed/27881040
Neurology
No
01/13/2017
3913
Amyotrophic lateral sclerosis
Cacabelos D, Ayala V, Granado-Serrano AB et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016 Jan 12;88:148-160. doi: 10.1016/j.nbd.2016.01.007. [Epub ahead of print]
English
Cacabelos D, Ayala V, Granado-Serrano AB et al. Interplay between TDP-43 and docosahexaenoic acid-related processes in amyotrophic lateral sclerosis. Neurobiol Dis. 2016 Jan 12;88:148-160. doi: 10.1016/j.nbd.2016.01.007. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26805387
Amyotrophic lateral sclerosis
No
2016-01-12 00:00:00
3429
Autism
Parellada M, Llorente C, Calvo R, et al. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Sep 18.
English
Parellada M, Llorente C, Calvo R, et al. Randomized trial of omega-3 for autism spectrum disorders: Effect on cell membrane composition and behavior. Eur Neuropsychopharmacol. 2017 Sep 18.
https://www.ncbi.nlm.nih.gov/pubmed/28935269
Autism
No
2017-09-18 00:00:00
4404
Sheppard KW, Boone KM, Gracious B, Klebanoff MA, Rogers LK, Rausch J, et al. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord. 2017 Jul 26. [Epub ahead of print]
English
Sheppard KW, Boone KM, Gracious B, Klebanoff MA, Rogers LK, Rausch J, et al. Effect of Omega-3 and -6 Supplementation on Language in Preterm Toddlers Exhibiting Autism Spectrum Disorder Symptoms. J Autism Dev Disord. 2017 Jul 26. [Epub ahead of print]
https://www.ncbi.nlm.nih.gov/pubmed/28748334
Autism
No
2017-07-26 00:00:00
4329
Brigandi SA, Shao H, Qian SY et al. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061.
English
Brigandi SA, Shao H, Qian SY et al. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061.
http://www.mdpi.com/1422-0067/16/5/10061/htm
Autism
Full text
2015-05-04 00:00:00
2530
Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061.
English
Brigandi SA, Shao H, Qian SY, Shen Y, Wu BL, Kang JX. Autistic children exhibit decreased levels of essential Fatty acids in red blood cells. Int J Mol Sci. 2015 May 4;16(5):10061-76. doi: 10.3390/ijms160510061.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4463632/
Autism
Full text
2015-05-04 00:00:00
2534
Yan CL, Zhang J, Hou Y. Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders. Neuroreport. 2015 Apr 15;26(6):341-5. doi: 10.1097/WNR.
English
Yan CL, Zhang J, Hou Y. Decreased plasma levels of lipoxin A4 in children with autism spectrum disorders. Neuroreport. 2015 Apr 15;26(6):341-5. doi: 10.1097/WNR.
http://www.ncbi.nlm.nih.gov/pubmed/25714424
Autism
No
2015-04-15 00:00:00
2538
Ooi YP, Weng SJ, Jang LY, Low L, Seah J, Teo S, Ang RP, Lim CG, Liew A, Fung DS, Sung M. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr. 2015 Mar 25. doi: 10.1038/e
English
Ooi YP, Weng SJ, Jang LY, Low L, Seah J, Teo S, Ang RP, Lim CG, Liew A, Fung DS, Sung M. Omega-3 fatty acids in the management of autism spectrum disorders: findings from an open-label pilot study in Singapore. Eur J Clin Nutr. 2015 Mar 25. doi: 10.1038/ejcn.2015.28.
http://www.ncbi.nlm.nih.gov/pubmed/25804268
Autism
No
2015-03-25 00:00:00
2537
Al-Farsi YM, Waly MI, Deth RC et al. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition. 2013;29(9):1142-1146.
English
Al-Farsi YM, Waly MI, Deth RC et al. Impact of nutrition on serum levels of docosahexaenoic acid among Omani children with autism. Nutrition. 2013;29(9):1142-1146.
http://www.ncbi.nlm.nih.gov/pubmed/23800562
Autism
No
2013-01-01 00:00:00
2524
Bent S, Bertoglio K, Ashwood P et al. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011 May;41(5):545-54.
English
Bent S, Bertoglio K, Ashwood P et al. A pilot randomized controlled trial of omega-3 fatty acids for autism spectrum disorder. J Autism Dev Disord. 2011 May;41(5):545-54.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3076562/pdf/10803_2010_Article_1078.pdf
Autism
Full text
2011-05-02 00:00:00
2529
Cognitive decline
Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementat
English
Famenini S, Rigali EA, Olivera-Perez HM, Dang J, Chang MT, Halder R, Rao RV, Pellegrini M, Porter V, Bredesen D, Fiala M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on ω-3 supplementation. FASEB J. 2017 Jan;31(1):148-160.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5161513/
Cognitive decline
Full text
2017-01-01 00:00:00
3944
Cutuli D. Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr Neuropharmacol. 2016 Jun 13. [Epub ahead of print]
English
Cutuli D. Functional and structural benefits induced by omega-3 polyunsaturated fatty acids during aging. Curr Neuropharmacol. 2016 Jun 13. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/27306037
Cognitive decline
No
2016-06-13 00:00:00
3483
Hashimoto M, Kato S, Tanabe Y et al. Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr Gerontol Int. 2016 Jan 28. doi: 10.11
English
Hashimoto M, Kato S, Tanabe Y et al. Beneficial effects of dietary docosahexaenoic acid intervention on cognitive function and mental health of the oldest elderly in Japanese care facilities and nursing homes. Geriatr Gerontol Int. 2016 Jan 28. doi: 10.1111/ggi.12691. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26822516
Cognitive decline
No
2016-01-28 00:00:00
3486
Oulhaj A, Jernerén F, Refsum H et al. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2016 Jan 6. [Epub ahead of print]
English
Oulhaj A, Jernerén F, Refsum H et al. Omega-3 Fatty Acid Status Enhances the Prevention of Cognitive Decline by B Vitamins in Mild Cognitive Impairment. J Alzheimers Dis. 2016 Jan 6. [Epub ahead of print]
http://content.iospress.com/articles/journal-of-alzheimers-disease/jad150777
Cognitive decline
Full text
2016-01-06 00:00:00
3487
Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with
English
Köbe T, Witte AV, Schnelle A, Lesemann A, Fabian S, Tesky VA, Pantel J, Flöel A. Combined omega-3 fatty acids, aerobic exercise and cognitive stimulation prevents decline in gray matter volume of the frontal, parietal and cingulate cortex in patients with mild cognitive impairment. Neuroimage. 2015 Oct 1. pii: S1053-8119(15)00872-1.
http://www.ncbi.nlm.nih.gov/pubmed/26433119
Cognitive decline
No
2015-10-01 00:00:00
3103
Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21.
English
Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21.
http://www.ncbi.nlm.nih.gov/pubmed/25877495
Cognitive decline
No
2015-07-01 00:00:00
3168
Rathod RS, Khaire AA, Kale AA, Joshi SR. “Beneficial effects of omega-3 fatty acids and vitamin B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive performance in the second-generation Wistar rats.” Abstract
English
Rathod RS, Khaire AA, Kale AA, Joshi SR. Beneficial effects of omega-3 fatty acids and vitamin B12 supplementation on brain docosahexaenoic acid, brain derived neurotrophic factor, and cognitive performance in the second-generation Wistar rats. Biofactors. 2015 Jul-Aug;41(4):261-72.
http://www.ncbi.nlm.nih.gov/pubmed/26249019
Cognitive decline
No
2015-07-01 00:00:00
2533
Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. “Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial.” Am J Clin Nutr. 2015 Jul;102(1):215-21.
English
Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Jul;102(1):215-21.
http://www.ncbi.nlm.nih.gov/pubmed/25877495
Cognitive decline
No
2015-07-01 00:00:00
2548
Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. “An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases.” J Physiol Biochem. 2015 Jun;71(2):341-9. doi: 10.1007/s13105-0
English
Lorente-Cebrián S, Costa AG, Navas-Carretero S, Zabala M, Laiglesia LM, Martínez JA, Moreno-Aliaga MJ. An update on the role of omega-3 fatty acids on inflammatory and degenerative diseases. J Physiol Biochem. 2015 Jun;71(2):341-9. doi: 10.1007/s13105-015-0395-y.
http://www.ncbi.nlm.nih.gov/pubmed/25752887
Cognitive decline
No
2015-06-01 00:00:00
2559
Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan TG. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress. Psychoneuroendocrinology. 2015 Apr 28;58:79-90. doi: 10.1016/j.psyneuen.2015.04.015.
English
Pusceddu MM, Kelly P, Ariffin N, Cryan JF, Clarke G, Dinan TG. n-3 PUFAs have beneficial effects on anxiety and cognition in female rats: Effects of early life stress. Psychoneuroendocrinology. 2015 Apr 28;58:79-90. doi: 10.1016/j.psyneuen.2015.04.015.
http://www.ncbi.nlm.nih.gov/pubmed/25965872
Cognitive decline
No
2015-04-28 00:00:00
2624
Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Apr 15. pii: ajcn103
English
Jernerén F, Elshorbagy AK, Oulhaj A, Smith SM, Refsum H, Smith AD. Brain atrophy in cognitively impaired elderly: the importance of long-chain ω-3 fatty acids and B vitamin status in a randomized controlled trial. Am J Clin Nutr. 2015 Apr 15. pii: ajcn103283.
http://www.ncbi.nlm.nih.gov/pubmed/25877495
Cognitive decline
No
2015-04-15 00:00:00
2617
Dehkordi NG, Noorbakhshnia M, Ghaedi K, Esmaeili A, Dabaghi M. Omega-3 fatty acids prevent LPS-induced passive avoidance learning and memory and CaMKII-α gene expression impairments in hippocampus of rat. Pharmacol Rep. 2015 Apr;67(2):370-5. doi: 10.1016/
English
Dehkordi NG, Noorbakhshnia M, Ghaedi K, Esmaeili A, Dabaghi M. Omega-3 fatty acids prevent LPS-induced passive avoidance learning and memory and CaMKII-α gene expression impairments in hippocampus of rat. Pharmacol Rep. 2015 Apr;67(2):370-5. doi: 10.1016/j.pharep.2014.10.014.
http://www.ncbi.nlm.nih.gov/pubmed/25712666
Cognitive decline
No
2015-04-01 00:00:00
2614
Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Ma
English
Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9. doi: 10.1096/fj.14-264218. Epub 2015 Mar 24.
http://www.ncbi.nlm.nih.gov/pubmed/25805829
Cognitive decline
No
2015-03-24 00:00:00
2572
Chang PK, Khatchadourian A, McKinney RA, Maysinger D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J Neuroinflammation. 2015 Dec;12(1):244. doi: 10.1186/s12974-015-0244-5.
English
Chang PK, Khatchadourian A, McKinney RA, Maysinger D. Docosahexaenoic acid (DHA): a modulator of microglia activity and dendritic spine morphology. J Neuroinflammation. 2015 Dec;12(1):244. doi: 10.1186/s12974-015-0244-5.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4344754/
Cognitive decline
Full text
2015-01-01 00:00:00
2613
Street SJ, Parletta N, Milte C, Sullivan K, Hills AP, Buckley J, Howe P. Interaction of erythrocyte eicosapentaenoic acid and physical activity predicts reduced risk of mild cognitive impairment. Aging Ment Health. 2015 Oct;19(10):885-91. doi: 10.1080/136
English
Street SJ, Parletta N, Milte C, Sullivan K, Hills AP, Buckley J, Howe P. Interaction of erythrocyte eicosapentaenoic acid and physical activity predicts reduced risk of mild cognitive impairment. Aging Ment Health. 2015 Oct;19(10):885-91. doi: 10.1080/13607863.2014.971705. Epub 2014 Nov 6.
http://www.ncbi.nlm.nih.gov/pubmed/25374153
Cognitive decline
No
2014-11-06 00:00:00
2579
Abdel-Wahab BA, Al-Qahtani JM, El-Safty SA. Omega-3 polyunsaturated fatty acids in large doses attenuate seizures, cognitive impairment, and hippocampal oxidative DNA damage in young kindled rats. Neurosci Lett. 2014 Oct 11. pii: S0304-3940(14)00806-4.
English
Abdel-Wahab BA, Al-Qahtani JM, El-Safty SA. Omega-3 polyunsaturated fatty acids in large doses attenuate seizures, cognitive impairment, and hippocampal oxidative DNA damage in young kindled rats. Neurosci Lett. 2014 Oct 11. pii: S0304-3940(14)00806-4.
http://www.ncbi.nlm.nih.gov/pubmed/25316163
Cognitive decline
No
2014-10-11 00:00:00
2580
Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary Omega-3 Fatty Acids Modulate Large-Scale Systems Organization in the Rhesus Macaque Brain. J Neurosci. 2014 Feb 5;34(6):2065-74. doi: 10.1523/JNEUROSCI.3038-13.2014.
English
Grayson DS, Kroenke CD, Neuringer M, Fair DA. Dietary Omega-3 Fatty Acids Modulate Large-Scale Systems Organization in the Rhesus Macaque Brain. J Neurosci. 2014 Feb 5;34(6):2065-74. doi: 10.1523/JNEUROSCI.3038-13.2014.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913863/
Cognitive decline
Full text
2014-02-04 00:00:00
2592
Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706.
English
Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824191/
Cognitive decline
Full text
2013-11-01 00:00:00
2630
O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In P
English
O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In Press, Accepted Manuscript.
http://www.ncbi.nlm.nih.gov/pubmed/24342530
Cognitive decline
No
2013-10-03 00:00:00
2601
O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In P
English
O’Callaghan N, Parletta N, Milte CM et al. Telomere shortening in elderly people with mild cognitive impairment may be attenuated with omega-3 fatty acid supplementation: A randomised controlled pilot study. Nutrition. Available online 3 October 2013.In Press, Accepted Manuscript.
http://www.sciencedirect.com/science/article/pii/S0899900713004450
Cognitive decline
No
2013-10-01 00:00:00
2623
Witte AV, Kerti L, Hermannstädter HM et al. Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cereb Cortex. 2013 Jun 24.
English
Witte AV, Kerti L, Hermannstädter HM et al. Long-Chain Omega-3 Fatty Acids Improve Brain Function and Structure in Older Adults. Cereb Cortex. 2013 Jun 24.
http://www.ncbi.nlm.nih.gov/pubmed/23796946
Cognitive decline
No
2013-06-24 00:00:00
2605
Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 2013 Mar;12(2):579-94.
English
Denis I, Potier B, Vancassel S, Heberden C, Lavialle M. Omega-3 fatty acids and brain resistance to ageing and stress: body of evidence and possible mechanisms. Ageing Res Rev. 2013 Mar;12(2):579-94.
http://www.ncbi.nlm.nih.gov/pubmed/23395782
Cognitive decline
No
2013-03-12 00:00:00
2591
Avramovic N, Dragutinovic V, Krstic D et al. The effects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged wistar rats. Hippokratia. 2012 Jul;16(3):241-5.
English
Avramovic N, Dragutinovic V, Krstic D et al. The effects of omega 3 fatty acid supplementation on brain tissue oxidative status in aged wistar rats. Hippokratia. 2012 Jul;16(3):241-5.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738731/
Cognitive decline
Full text
2012-07-16 00:00:00
2585
Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11
English
Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11:99.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564898/pdf/1475-2891-11-99.pdf
Cognitive decline
Full text
2012-01-01 00:00:00
2598
Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012; 78:241-249.
English
Bowman GL, Silbert LC, Howieson D, Dodge HH, Traber MG, Frei B, Kaye JA, Shannon J, Quinn JF. Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging. Neurology. 2012; 78:241-249.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3280054/
Cognitive decline
Full text
2012-01-01 00:00:00
2588
Tan ZS, Harris WS, Beiser AS et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012; 78:658-664.
English
Tan ZS, Harris WS, Beiser AS et al. Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging. Neurology. 2012; 78:658-664.
http://www.neurology.org/content/78/9/658
Cognitive decline
No
2012-01-01 00:00:00
2602
Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E, Helmer C, Amieva H, Allard M, Dartigues JF, Cunnane SC, Mazoyer BM, Barberger-Gateau P. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology. 2012; 79:642-65
English
Samieri C, Maillard P, Crivello F, Proust-Lima C, Peuchant E, Helmer C, Amieva H, Allard M, Dartigues JF, Cunnane SC, Mazoyer BM, Barberger-Gateau P. Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe. Neurology. 2012; 79:642-650.
http://www.neurology.org/content/79/7/642
Cognitive decline
No
2012-01-01 00:00:00
2629
Matesanz N, Park G, McAllister H et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6815-25.
English
Matesanz N, Park G, McAllister H et al. Docosahexaenoic acid improves the nitroso-redox balance and reduces VEGF-mediated angiogenic signaling in microvascular endothelial cells. Invest Ophthalmol Vis Sci. 2010 Dec;51(12):6815-25.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055780/
Cognitive decline
No
2010-12-01 00:00:00
2597
Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013.
English
Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013.
http://www.ncbi.nlm.nih.gov/pubmed/?term=Yurko-Mauro%20K%2C%20McCarthy%20D%2C%20Rom%20D%202010
Cognitive decline
No
2010-11-06 00:00:00
2606
Zhang F, Yang H, Pan Z et al. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5601-9.
English
Zhang F, Yang H, Pan Z et al. Dependence of resolvin-induced increases in corneal epithelial cell migration on EGF receptor transactivation. Invest Ophthalmol Vis Sci. 2010 Nov;51(11):5601-9.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3061499/
Cognitive decline
Full text
2010-11-01 00:00:00
2609
Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013.
English
Yurko-Mauro K, McCarthy D, Rom D et al. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 2010 Nov;6(6):456-64. doi: 10.1016/j.jalz.2010.01.013.
http://www.ncbi.nlm.nih.gov/pubmed/?term=Yurko-Mauro%20K%2C%20McCarthy%20D%2C%20Rom%20D%202010
Deterioro cognitivo
No
2010-01-13 00:00:00
2633
Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins and neural function. Annual Review of Cell and Development Biology 2005; 21: 633-657.
English
Marszalek JR, Lodish HF. Docosahexaenoic acid, fatty acid-interacting proteins and neural function. Annual Review of Cell and Development Biology 2005; 21: 633-657.
http://www.ncbi.nlm.nih.gov/pubmed/16212510
Cognitive decline
No
2005-01-01 00:00:00
2618
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33.
English
Cenacchi T, Bertoldin T, Farina C, Fiori MG, Crepaldi G. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging Clin Exp Res 1993; 5: 123-33.
http://www.ncbi.nlm.nih.gov/pubmed/8323999
Deterioro cognitivo
No
1993-01-01 00:00:00
2610
Cystic fibrosis
Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. PLoS One. 2017;12(2):e0171249.
English
Eickmeier O, Fussbroich D, Mueller K, Serve F, Smaczny C, Zielen S, et al. Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. PLoS One. 2017;12(2):e0171249.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291435/pdf/pone.0171249.pdf
Cystic fibrosis
Full text
2017-07-12 00:00:00
4254
Eickmeier O, Fussbroich D, MuellerK, Serve F, Smaczny C, Zielen S, Schubert R, Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. 2017 February 3
English
Eickmeier O, Fussbroich D, MuellerK, Serve F, Smaczny C, Zielen S, Schubert R, Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis. 2017 February 3
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0171249
Fibrosis quística
Full text
2017-05-31 00:00:00
4030
Hanssens L, Thiébaut I, Lefèvre N et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.01
English
Hanssens L, Thiébaut I, Lefèvre N et al. The clinical benefits of long-term supplementation with omega-3 fatty acids in cystic fibrosis patients - A pilot study. Prostaglandins Leukot Essent Fatty Acids. 2016 May;108:45-50. doi: 10.1016/j.plefa.2016.03.014. Epub 2016 Mar 28.
http://www.ncbi.nlm.nih.gov/pubmed/27154364
Cystic fibrosis
No
2016-03-28 00:00:00
3413
Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev. 2016 Jan 5;1:CD002201. [Epub ahead of print]
English
Oliver C, Watson H. Omega-3 fatty acids for cystic fibrosis. Cochrane Database Syst Rev. 2016 Jan 5;1:CD002201. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26730723
Cystic fibrosis
No
2016-01-05 00:00:00
3416
Dementia and Alzheimer
Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review Robert A. Whittington, Emmanuel Planel and Niccolò Terrando
English
Impaired Resolution of Inflammation in Alzheimer’s Disease: A Review Robert A. Whittington, Emmanuel Planel and Niccolò Terrando
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5681480/
Demencia y Alzheimer
No
2017-11-06 00:00:00
4429
Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS). Prostaglandins Le
English
Ammann EM, Pottala JV, Robinson JG, Espeland MA, Harris WS. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS). Prostaglandins Leukot Essent Fatty Acids. 2017;121:68-75.
https://www.ncbi.nlm.nih.gov/pubmed/28651700
Dementia and Alzheimer
No
2017-06-21 00:00:00
4333
Nock TG, Chouinard-Watkins R, Plourde M. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline. Biochim Biophys Acta. 2017 Jul 18;1862(10 Pt A):1068-1078.
English
Nock TG, Chouinard-Watkins R, Plourde M. Carriers of an apolipoprotein E epsilon 4 allele are more vulnerable to a dietary deficiency in omega-3 fatty acids and cognitive decline. Biochim Biophys Acta. 2017 Jul 18;1862(10 Pt A):1068-1078.
https://www.ncbi.nlm.nih.gov/pubmed/28733268
Dementia and Alzheimer
No
2017-06-15 00:00:00
4334
Grimm MO, Michaelson D, Hartmann T. Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017 May 20.
English
Grimm MO, Michaelson D, Hartmann T. Omega-3 fatty acids, lipids and apoE lipidation in Alzheimer's disease: a rationale for multi-nutrient dementia prevention. J Lipid Res. 2017 May 20.
http://www.jlr.org/content/early/2017/05/20/jlr.R076331.full.pdf
Dementia and Alzheimer
Full text
2017-05-31 00:00:00
4156
Fiala M, Kooij G, Wagner K et al. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J. 2017 Apr 18.
English
Fiala M, Kooij G, Wagner K et al. Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids. FASEB J. 2017 Apr 18.
https://www.ncbi.nlm.nih.gov/pubmed/28420693
Dementia and Alzheimer
No
2017-05-01 00:00:00
4155
Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347.
English
Yassine HN, Braskie MN, Mack WJ, Castor KJ, Fonteh AN, Schneider LS, Harrington MG, Chui HC. Association of Docosahexaenoic Acid Supplementation With Alzheimer Disease Stage in Apolipoprotein E ε4 Carriers: A Review. JAMA Neurol. 2017 Mar 1;74(3):339-347.
https://www.ncbi.nlm.nih.gov/pubmed/28114437
Dementia and Alzheimer
No
2017-03-01 00:00:00
3947
Yanai H. Effects of N-3 Polyunsaturated Fatty Acids on Dementia. J Clin Med Res. 2017 Jan;9(1):1-9.
English
Yanai H. Effects of N-3 Polyunsaturated Fatty Acids on Dementia. J Clin Med Res. 2017 Jan;9(1):1-9.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127208/
Dementia and Alzheimer
Full text
2017-01-01 00:00:00
3954
Ren H, Luo C, Feng Y Yao X, Shi Z, Liang F, Kang JX, Wan JB, Pei Z, Su H. Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017 Jan;31(1):282-293.
English
Ren H, Luo C, Feng Y Yao X, Shi Z, Liang F, Kang JX, Wan JB, Pei Z, Su H. Omega-3 polyunsaturated fatty acids promote amyloid-β clearance from the brain through mediating the function of the glymphatic system. FASEB J. 2017 Jan;31(1):282-293.
https://www.ncbi.nlm.nih.gov/pubmed/27789520
Dementia and Alzheimer
No
2017-01-01 00:00:00
3950
Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, Lagarde M, Bernoud-Hubac N. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem. 2016 Dec;38:1-11.
English
Belkouch M, Hachem M, Elgot A, Lo Van A, Picq M, Guichardant M, Lagarde M, Bernoud-Hubac N. The pleiotropic effects of omega-3 docosahexaenoic acid on the hallmarks of Alzheimer's disease. J Nutr Biochem. 2016 Dec;38:1-11.
https://www.ncbi.nlm.nih.gov/pubmed/27825512
Dementia and Alzheimer
No
2016-12-01 00:00:00
3949
Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blümel T, Stötzel H, Grimm HS, Hartmann T. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016 Dec;94(6):534-542
English
Grimm MO, Mett J, Stahlmann CP, Haupenthal VJ, Blümel T, Stötzel H, Grimm HS, Hartmann T. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme. Biochem Cell Biol. 2016 Dec;94(6):534-542.
https://www.ncbi.nlm.nih.gov/pubmed/27813426
Dementia and Alzheimer
No
2016-12-01 00:00:00
3953
Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fa
English
Eriksdotter M, Vedin I, Falahati F, Freund-Levi Y, Hjorth E, Faxen-Irving G, Wahlund LO, Schultzberg M, Basun H, Cederholm T, Palmblad J. Plasma Fatty Acid Profiles in Relation to Cognition and Gender in Alzheimer's Disease Patients During Oral Omega-3 Fatty Acid Supplementation: The OmegAD Study. J Alzheimers Dis. 2015 Oct 1;48(3):805-12.
http://www.ncbi.nlm.nih.gov/pubmed/26402079
Dementia and Alzheimer
No
2015-10-01 00:00:00
3106
Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9.
English
Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Jul;29(7):2681-9.
http://www.ncbi.nlm.nih.gov/pubmed/25805829
Dementia and Alzheimer
No
2015-07-01 00:00:00
2569
Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease. J Neurosci. 2015 Jun 17;35(24):9173-81.
English
Casali BT, Corona AW, Mariani MM, Karlo JC, Ghosal K, Landreth GE. Omega-3 Fatty Acids Augment the Actions of Nuclear Receptor Agonists in a Mouse Model of Alzheimer's Disease. J Neurosci. 2015 Jun 17;35(24):9173-81.
http://www.ncbi.nlm.nih.gov/pubmed/26085639
Dementia and Alzheimer
No
2015-06-17 00:00:00
2563
Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Mar 24. pii: fj.14-264218.
English
Fiala M, Halder RC, Sagong B, Ross O, Sayre J, Porter V, Bredesen DE. ω-3 Supplementation increases amyloid-β phagocytosis and resolvin D1 in patients with minor cognitive impairment. FASEB J. 2015 Mar 24. pii: fj.14-264218.
http://www.ncbi.nlm.nih.gov/pubmed/25805829
Dementia and Alzheimer
No
2015-03-24 00:00:00
2640
Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers D
English
Shinto L, Quinn J, Montine T, Dodge HH, Woodward W, Baldauf-Wagner S, Waichunas D, Bumgarner L, Bourdette D, Silbert L, Kaye J. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J Alzheimers Dis. 2014;38(1):111-20. doi: 10.3233/JAD-130722.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3886557/
Dementia and Alzheimer
Full text
2014-01-01 00:00:00
2653
Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706.
English
Wiesmann M, Kiliaan AJ, Claassen JA. Vascular aspects of cognitive impairment and dementia. J Cereb Blood Flow Metab. 2013 Nov;33(11):1696-706.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3824191/
Dementia and Alzheimer
Full text
2013-11-01 00:00:00
2654
Zhao Y, Calon F, Julien C et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR?-mediated mechanisms in Alzheimer's disease models. PLoS One. 2011 Jan 5;6(1):e15816.
English
Zhao Y, Calon F, Julien C et al. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase- and PPAR?-mediated mechanisms in Alzheimer's disease models. PLoS One. 2011 Jan 5;6(1):e15816.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3016440/pdf/pone.0015816.pdf
Dementia and Alzheimer
Full text
2011-01-05 00:00:00
2659
Caballer García J. Los ácidos grasos omega-3 en la prevención de la enfermedad de Alzheimer. Alzheimer. Real Invest Demenc. 2011;49:12-18.
English
Caballer García J. Los ácidos grasos omega-3 en la prevención de la enfermedad de Alzheimer. Alzheimer. Real Invest Demenc. 2011;49:12-18.
http://revistaalzheimer.com/PDF/0239.pdf
Dementia and Alzheimer
Full text
2011-01-01 00:00:00
2637
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17)
English
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, Shinto L, Aisen PS. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA. 2010 Nov 3;304(17):1903-11.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259852/
Dementia and Alzheimer
Full text
2010-11-03 00:00:00
2650
Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010 Apr 7;5:45-61.
English
Jicha GA, Markesbery WR. Omega-3 fatty acids: potential role in the management of early Alzheimer's disease. Clin Interv Aging. 2010 Apr 7;5:45-61.
https://www.dovepress.com/getfile.php?fileID=5956
Dementia and Alzheimer
Full text
2010-04-07 00:00:00
2646
Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009 Mar;5(3):140-52.
English
Fotuhi M, Mohassel P, Yaffe K. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat Clin Pract Neurol. 2009 Mar;5(3):140-52.
http://www.ncbi.nlm.nih.gov/pubmed/19262590
Dementia and Alzheimer
No
2009-03-05 00:00:00
2643
Palmblad J, Eriksdotter-Jönhagen M, Freund-Levi Y, Cederholm T. Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited. Lakartidningen. 2007 Oct 31-Nov 6;104(44):3268-71.
English
Palmblad J, Eriksdotter-Jönhagen M, Freund-Levi Y, Cederholm T. Omega-3-fatty acids protect against dementia. Also early symptoms of mild Alzheimer disease seem to be inhibited. Lakartidningen. 2007 Oct 31-Nov 6;104(44):3268-71.
http://www.ncbi.nlm.nih.gov/pubmed/18050989
Dementia and Alzheimer
No
2007-10-31 00:00:00
2649
Epilepsy
Tejada S, Martorell M, Capó X et al. Omega-3 Fatty Acids in the Management of Epilepsy. Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print]
English
Tejada S, Martorell M, Capó X et al. Omega-3 Fatty Acids in the Management of Epilepsy. Curr Top Med Chem. 2016 Feb 4. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26845549
Epilepsy
No
2016-02-04 00:00:00
3409
Scorza FA. Sudden unexpected death in children with epilepsy: Focus on dietary supplementation with omega-3 polyunsaturated fatty acids. Epilepsy Behav. 2015 Feb 25;44C:169-170. doi: 10.1016/j.yebeh.2015.01.002.
English
Scorza FA. Sudden unexpected death in children with epilepsy: Focus on dietary supplementation with omega-3 polyunsaturated fatty acids. Epilepsy Behav. 2015 Feb 25;44C:169-170. doi: 10.1016/j.yebeh.2015.01.002.
http://www.ncbi.nlm.nih.gov/pubmed/25725327
Epilepsy
No
2015-02-25 00:00:00
3020
Taha AY, Ciobanu FA, Saxena A, McIntyre Burnham W. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy. Epilepsy Behav. 2009 Jan;14(1):27-31. Epub 2008 Dec 2.
English
Taha AY, Ciobanu FA, Saxena A, McIntyre Burnham W. Assessing the link between omega-3 fatty acids, cardiac arrest, and sudden unexpected death in epilepsy. Epilepsy Behav. 2009 Jan;14(1):27-31. Epub 2008 Dec 2.
http://www.ncbi.nlm.nih.gov/pubmed/18992844
Epilepsy
No
2008-12-02 00:00:00
3023
Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA. The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 2008 Aug;13(2):279-83.
English
Scorza FA, Cysneiros RM, Arida RM, Terra-Bustamante VC, de Albuquerque M, Cavalheiro EA. The other side of the coin: Beneficiary effect of omega-3 fatty acids in sudden unexpected death in epilepsy. Epilepsy Behav. 2008 Aug;13(2):279-83.
http://www.ncbi.nlm.nih.gov/pubmed/18511348
Epilepsy
No
2008-08-01 00:00:00
3019
Memory
Zamroziewicz MK, Paul EJ, Zwilling CE, et al. Predictors of Memory in Healthy Aging: Polyunsaturated Fatty Acid Balance and Fornix White Matter Integrity. Aging Dis. 2017 Jul 21;8(4):372-83.
English
Zamroziewicz MK, Paul EJ, Zwilling CE, et al. Predictors of Memory in Healthy Aging: Polyunsaturated Fatty Acid Balance and Fornix White Matter Integrity. Aging Dis. 2017 Jul 21;8(4):372-83.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5524800/
Memory
Full text
2017-07-21 00:00:00
4413
Külzow N, Witte AV, Kerti L et al. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults. J Alzheimers Dis. 2016 Feb 10. [Epub ahead of print]
English
Külzow N, Witte AV, Kerti L et al. Impact of Omega-3 Fatty Acid Supplementation on Memory Functions in Healthy Older Adults. J Alzheimers Dis. 2016 Feb 10. [Epub ahead of print]
http://www.ncbi.nlm.nih.gov/pubmed/26890759
Memory
No
2016-02-10 00:00:00
3491
Boespflug EL, McNamara RK, Eliassen JC et al. Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment. J Nutr Health Aging. 2016;20(2):161-9. doi: 10.1007/s12603-015-0609-6.
English
Boespflug EL, McNamara RK, Eliassen JC et al. Fish Oil Supplementation Increases Event-Related Posterior Cingulate Activation in Older Adults with Subjective Memory Impairment. J Nutr Health Aging. 2016;20(2):161-9. doi: 10.1007/s12603-015-0609-6.
http://www.ncbi.nlm.nih.gov/pubmed/26812512
Memory
No
2016-02-01 00:00:00
3490
Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int. 2015 Oct;89:51-62.
English
Gharami K, Das M, Das S. Essential role of docosahexaenoic acid towards development of a smarter brain. Neurochem Int. 2015 Oct;89:51-62.
http://www.ncbi.nlm.nih.gov/pubmed/26321578
Memory
No
2015-10-01 00:00:00
3102
Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11
English
Nilsson A, Radeborg K, Salo I et al. Effects of supplementation with n-3 polyunsaturated fatty acids on cognitive performance and cardiometabolic risk markers in healthy 51 to 72 years old subjects: a randomized controlled cross-over study. Nutr J 2012;11:99.
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564898/pdf/1475-2891-11-99.pdf
Memory
Full text
2012-01-01 00:00:00
2566
Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010
English
Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord. 2010;29(5):467-74.
http://www.ncbi.nlm.nih.gov/pubmed/20523044
Memory
No
2010-01-01 00:00:00
2571
Frais AT. Depression and the causal role of specific memory system degenerations: link may be supported by reported therapeutic benefits of Omega 3 fatty acids. Med Hypotheses. 2007;69(1):67-9.
English
Frais AT. Depression and the causal role of specific memory system degenerations: link may be supported by reported therapeutic benefits of Omega 3 fatty acids. Med Hypotheses. 2007;69(1):67-9.
http://www.ncbi.nlm.nih.gov/pubmed/17368750
Memory
No
2007-01-01 00:00:00
2565